Edwards Lifesciences CorpEW

Market cap

$49.9B

P/E ratio

	Dec 31, 2010	Dec 31, 2011	Dec 31, 2012	Dec 31, 2013	Dec 31, 2014	Dec 31, 2015	Dec 31, 2016	Dec 31, 2017	Dec 31, 2018	Dec 31, 2019	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024
Net sales	-	-	-	-	-	-	-	-	3,723	4,348	4,386	5,233	5,382	6,005	5,440
Cost of sales	408	490	495	522	626	617	797	875	939	1,114	1,081	1,249	1,080	1,380	1,118
Gross profit	1,039	1,189	1,405	1,523	1,697	1,877	2,166	2,560	2,783	3,234	3,306	3,984	4,302	4,625	4,322
Selling, General and Administrative Expense	550	642	705	746	858	851	905	985	1,089	1,242	1,228	1,494	1,568	1,825	1,789
Research and Development Expense	204	246	291	323	347	383	443	553	622	753	761	903	945	1,072	1,053
Litigation Settlement, Fee Expense	-	-	-	-	-	-	33	-73	214	33	405	21	16	-	40
Change in fair value of contingent consideration liabilities (Note 13)	-	-	-	-	-	-	-	-10	-6	-6	14	-124	-36	-26	-
Restructuring, Settlement and Impairment Provisions	-	-	-	-	-	-	-	-	-	-	-	-	-	-	61
Other operating income, net	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0
Operating income	-	-	-	-	-	-	-	-	748	1,147	898	1,690	1,749	1,534	1,379
Interest expense	-	-	-	-	-	-	-	-	-	-	-	-	-	-	20
Interest income	1	3	5	5	6	8	11	20	32	32	23	17	36	67	120
Other non-operating income, net (Note 18)	-	-	-	-	-	-	-5	-8	4	8	12	13	3	14	69
Income from continuing operations before provision for income taxes	-	-	-	-	-	-	-	-	-	-	-	1,702	1,767	1,598	1,548
Income Tax Expense (Benefit)	50	47	98	124	333	128	168	451	39	120	93	199	246	199	152
Net income from continuing operations	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1,396
Income from discontinued operations, net of tax	-	-	-	-	-	-	-	-	-	-	-	-	-	-	2,774
Net income	218	-	-	-	-	-	-	-	-	-	-	-	-	1,399	4,170
Net loss attributable to noncontrolling interest	-	-	-	-	-	-	-	-	-	-	-	-	-	-3	-5
Net income attributable to Edwards Lifesciences Corporation.	218	-	-	-	-	-	-	-	-	-	-	-	-	1,402	4,175
Continuing operations (in dollars per share)	-	-	-	-	-	-	-	-	-	-	-	-	-	-	2.34
Discontinued operations (in dollars per share)	-	-	-	-	-	-	-	-	-	-	-	-	-	-	4.64
Basic earnings per share (in dollars per share)	1.92	2.07	2.55	3.51	7.62	2.3	2.67	2.77	3.45	5.03	1.32	2.41	2.46	2.31	6.98
Continuing operations (in dollars per share)	-	-	-	-	-	-	-	-	-	-	-	-	-	-	2.34
Discontinued operations (in dollars per share)	-	-	-	-	-	-	-	-	-	-	-	-	-	-	4.63
Diluted earnings per share (in dollars per share)	1.83	1.98	2.48	3.44	7.48	2.25	2.61	2.7	3.38	4.93	1.3	2.38	2.44	2.3	6.97